Interactive Cases

An Introduction to Atopic Dermatitis

Array

Activity Info

Welcome to this highly-visual, interactive module on atopic dermatitis (AD). The module will increase your understanding about the pathophysiology of AD, recently approved and emerging therapies, and their unique mechanisms of action. Ultimately, you will be armed with information to make better treatment choices to positively impact the management of your patients with AD.
Email

Activity Title: An Introduction to Atopic Dermatitis          
Topic: Atopic Dermatitis  
Accreditation Type: AMA PRA Category 1 Credit(s)™/MOC Points
Release Date: 5/31/2018    
Expiration Date: 5/30/2019    
Estimated Time to Complete Activity: 30 Minutes
 
LEARNING OBJECTIVES
Upon completion of the activity, participants should be able to:

  • Review key aspects of the pathophysiology and immunologic factors associated with AD that have come to light in recent years

 
FACULTY
Louis Kuritzky, MD
Clinical Assistant Professor Emeritus
University of Florida
Gainesville, Florida
 
Jonathan Silverberg, MD
Director, Northwestern Medicine Multidisciplinary Eczema Center
Director, Contact Dermatitis Clinic, Northwestern Memorial Hospital
Assistant Professor, Departments of Dermatology, Preventive Medicine and Medical Social Sciences
Northwestern University Feinberg School of Medicine
Chicago, Illinois
 
MOC REVIEWERS
Theodore Bruno, MD, FACEHP
Chief Medical Officer
The France Foundation
Old Lyme, Connecticut
 
Benjamin Garden, MD
The University of Illinois
Chicago, Illinois
 
METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT
Technical Requirements: https://www.francefoundation.com/general-requirements.html

  1. There are no fees for participating in and receiving credit for this activity. 
  2. Review the activity objectives and CME/CE information.
  3. Complete the CME/CE activity 
  4. Complete the online posttest. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed.
  5. Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
  6. Credit documentation/reporting:
    • If you are requesting AMA PRA Category 1 Credits™ or a certificate of participation—your CME/CE certificate will be available for download.
    • If you are requesting MOC credit, your MOC points will be submitted electronically to the ACCME, which will register data and notify certifying boards


 
ACCREDITED PROVIDER
This activity is provided by The France Foundation
 
TARGET AUDIENCE
This activity is intended for dermatologists, primary care physicians (including pediatricians, family physicians and internal medicine), nurse practitioners, and physician assistants.
 
STATEMENT OF NEED
In order to safely and appropriately select from among a wide range of emerging new therapies, dermatologists, primary care physicians and other health care practitioners must be able to understand key aspects of AD pathophysiology/immunology, how these factors relate to the mechanisms of action (MOA), and agent-specific characteristics and data. They must gain the ability to apply this new information in day-to-day practice, making selections (or referring for specialist management) based on these facts together with the individual patient’s particular characteristics.


ACCREDITATION STATEMENT
The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
CREDIT DESIGNATION
Physicians
The France Foundation designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
 
Nurses
Nurses who are certified by the American Nurses Credentialing Center (ANCC) may utilize activities that are certified by ACCME-accredited providers toward their requirement for certification renewal by the ANCC. A certificate of attendance will be provided by The France Foundation, an ACCME accredited provider.
 
DISCLOSURE POLICY
In accordance with the ACCME Standards for Commercial Support, The France Foundation requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TFF resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Furthermore, TFF seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.
 
Activity Staff Disclosures
The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.
 
Faculty Disclosures - Content/Activity Faculty
The following faculty report that they have relevant financial relationships to disclose:

  • Louis Kuritzky, MD, has served as a consultant for Amgen, Allergen, Boehringer Ingelheim, Lilly, Lundbeck, Novo Nordisk, Sanofi and Shire. He has served on the speakers bureau for Amgen.
  • Jonathan Silverberg, MD, has served as a consultant for Abbvie, Eli Lilly, Galderman, GlaxoSmithKline, Kiniksa, Menlo, Pfizer, Regeneron-Sanofi, Realm, and Roivant. He has served on the speakers bureau for Regeneron-Sanofi. Dr. Silverberg has received contract research from GlaxoSmithKline.


Reviewer Disclosure - MOC Reviewer
The following MOC reviewer reports that he has no relevant financial relationships to disclose:

  • Benjamin Garden, MD

 
REVIEWER DISCLOSURES - MOC REVIEWER
The following MOC reviewer reports that he has relevant financial relationships to disclose:

  • Theodore Bruno, MD, FACEHP, and his spouse are shareholders in Allergen and have received financial support from Allergen.

 
DISCLOSURE OF UNLABELED USE
TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

COMMERCIAL SUPPORT ACKNOWLEDGMENT
This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.


DISCLAIMER
The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.
 
COPYRIGHT INFORMATION
Copyright © 2018 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

  • The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
  • Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission.


PRIVACY POLICY
The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.

Additional information regarding The France Foundation’s Privacy Policy can be viewed here.

CONTACT INFORMATION
If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.